AMERICAN COLLEGE OF ENDOCRINOLOGY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$6,749,071
Investments
49%
Other Assets
39%
Receivables (Non-Related)
7%
Prepaid Expenses
3%
Cash & Equivalents
2%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$10,671,124
Other Liabilities
59%
Deferred Revenue
38%
Payables & Accruals
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$580,850
$166,701
-71%
Receivables (Non-Related)
$590,329
$443,165
-25%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$165,855
$224,039
+35%
Investments
$2,589,758
$3,306,251
+28%
Property, Plant, & Equipment (net)
$0
-
-
Other Assets
$2,752,819
$2,608,915
-5%
Total Assets
$6,679,611
$6,749,071
+1%
Liabilities
2023
2024
Change
Payables & Accruals
$347,834
$336,155
-3%
Grants Payable
-
-
-
Deferred Revenue
$3,425,060
$4,056,057
+18%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$5,687,869
$6,278,912
+10%
Total Liabilities
$9,460,763
$10,671,124
+13%
Net assets
2023
2024
Change
Restricted Net Assets
$1,333,325
$1,398,271
+5%
Unrestricted Net Assets
-$4,114,477
-$5,320,324
-29%
Net assets
2023
2024
Change
Net assets
-$2,781,152
-$3,922,053
-41%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)